These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 1427364)

  • 1. Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma.
    Iftikhar SY; James PD; Steele RJ; Hardcastle JD; Atkinson M
    Gut; 1992 Sep; 33(9):1155-8. PubMed ID: 1427364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superficial adenocarcinoma of the oesophagus arising in Barrett's mucosa with dysplasia: a clinico-pathological study of 12 patients.
    De Baecque C; Potet F; Molas G; Flejou JF; Barbier P; Martignon C
    Histopathology; 1990 Mar; 16(3):213-20. PubMed ID: 2332206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus.
    Miros M; Kerlin P; Walker N
    Gut; 1991 Dec; 32(12):1441-6. PubMed ID: 1773946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus.
    Sharma P; Weston AP; Topalovski M; Cherian R; Bhattacharyya A; Sampliner RE
    Gut; 2003 Jan; 52(1):24-7. PubMed ID: 12477754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of metaplastic non-goblet columnar lined oesophagus shows phenotypic similarities to Barrett's oesophagus: a study in an Asian population.
    Srivastava S; Liew MS; McKeon F; Xian W; Yeoh KG; Ho KY; Teh M
    Dig Liver Dis; 2014 Feb; 46(2):170-5. PubMed ID: 24290871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenocarcinoma and Barrett's oesophagus. A clinico-pathological study.
    Moghissi K; Sharpe DA; Pender D
    Eur J Cardiothorac Surg; 1993; 7(3):126-31. PubMed ID: 8461144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar lined oesophagus.
    Gray MR; Donnelly RJ; Kingsnorth AN
    Gut; 1993 Jun; 34(6):727-31. PubMed ID: 8314502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group.
    Menke-Pluymers MB; Hop WC; Dees J; van Blankenstein M; Tilanus HW
    Cancer; 1993 Aug; 72(4):1155-8. PubMed ID: 8339208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of symptom type and duration on the fate of the metaplastic columnar-lined Barrett's oesophagus.
    Gatenby PA; Ramus JR; Caygill CP; Fitzgerald RC; Charlett A; Winslet MC; Watson A
    Aliment Pharmacol Ther; 2009 May; 29(10):1096-105. PubMed ID: 19222408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barrett's esophagus: development of dysplasia and adenocarcinoma.
    Hameeteman W; Tytgat GN; Houthoff HJ; van den Tweel JG
    Gastroenterology; 1989 May; 96(5 Pt 1):1249-56. PubMed ID: 2703113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definition of Barrett's oesophagus.
    Van Eyken P
    Acta Gastroenterol Belg; 2000; 63(1):10-2. PubMed ID: 10907312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
    Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
    Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
    Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
    Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between smoking and severe dysplastic disease in patients with Barrett's columnar-lined oesophagus.
    Ramus JR; Gatenby PA; Caygill CP; Watson A; Winslet MC
    Eur J Cancer Prev; 2012 Nov; 21(6):507-10. PubMed ID: 22433630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A surveillance programme for Barrett's oesophagus in a UK general hospital.
    Olithselvan A; Gorard DA; McIntyre AS
    Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):305-9. PubMed ID: 17353694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short segment columnar-lined oesophagus: an underestimated cancer risk? A large cohort study of the relationship between Barrett's columnar-lined oesophagus segment length and adenocarcinoma risk.
    Gatenby PA; Caygill CP; Ramus JR; Charlett A; Fitzgerald RC; Watson A
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):969-75. PubMed ID: 18049166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routinely diagnosed low-grade dysplasia in Barrett's oesophagus: a population-based study of natural history.
    Gatenby P; Ramus J; Caygill C; Shepherd N; Winslet M; Watson A
    Histopathology; 2009 Jun; 54(7):814-9. PubMed ID: 19635100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barrett's oesophagus: intestinal metaplasia is not essential for cancer risk.
    Kelty CJ; Gough MD; Van Wyk Q; Stephenson TJ; Ackroyd R
    Scand J Gastroenterol; 2007 Nov; 42(11):1271-4. PubMed ID: 17852872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of the detection of intestinal metaplasia in non-dysplastic columnar-lined oesophagus.
    Gatenby PA; Ramus JR; Caygill CP; Shepherd NA; Watson A
    Scand J Gastroenterol; 2008; 43(5):524-30. PubMed ID: 18415743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of intragastric and intraoesophageal alkalinisation in the genesis of complications in Barrett's columnar lined lower oesophagus.
    Attwood SE; Ball CS; Barlow AP; Jenkinson L; Norris TL; Watson A
    Gut; 1993 Jan; 34(1):11-5. PubMed ID: 8432439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.